These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8793908

  • 1. Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase.
    Connop BP, Boegman RJ, Beninger RJ, Jhamandas K.
    Neuropharmacology; 1996 Apr; 35(4):459-65. PubMed ID: 8793908
    [Abstract] [Full Text] [Related]

  • 2. Malonate-induced degeneration of basal forebrain cholinergic neurons: attenuation by lamotrigine, MK-801, and 7-nitroindazole.
    Connop BP, Boegman RJ, Beninger RJ, Jhamandas K.
    J Neurochem; 1997 Mar; 68(3):1191-9. PubMed ID: 9048766
    [Abstract] [Full Text] [Related]

  • 3. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis.
    Connop BP, Boegman RJ, Jhamandas K, Beninger RJ.
    Brain Res; 1995 Apr 03; 676(1):124-32. PubMed ID: 7540931
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole.
    Connop BP, Rolfe NG, Boegman RJ, Jhamandas K, Beninger RJ.
    Neuropharmacology; 1994 Nov 03; 33(11):1439-45. PubMed ID: 7532827
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats.
    Maragos WF, Silverstein FS.
    J Neurochem; 1995 May 03; 64(5):2362-5. PubMed ID: 7536812
    [Abstract] [Full Text] [Related]

  • 6. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD, Manzino L, Sonsalla PK.
    Exp Neurol; 2000 Feb 03; 161(2):638-46. PubMed ID: 10686083
    [Abstract] [Full Text] [Related]

  • 7. Modulation of quinolinic acid-induced depletion of striatal NADPH diaphorase and enkephalinergic neurons by inhibition of nitric oxide synthase.
    Kalisch BE, Jhamandas K, Beninger RJ, Boegman RJ.
    Brain Res; 1999 Jan 30; 817(1-2):151-62. PubMed ID: 9889356
    [Abstract] [Full Text] [Related]

  • 8. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R, Muramatsu Y, Michimata M, Matsubara M, Kato H, Imai Y, Itoyama Y, Araki T.
    Neurol Res; 2002 Oct 30; 24(7):655-62. PubMed ID: 12392201
    [Abstract] [Full Text] [Related]

  • 9. Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats.
    Di Matteo V, Pierucci M, Benigno A, Esposito E, Crescimanno G, Di Giovanni G.
    CNS Neurosci Ther; 2010 Jun 30; 16(3):127-36. PubMed ID: 20345972
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset.
    Mackenzie GM, Jackson MJ, Jenner P, Marsden CD.
    Synapse; 1997 Jul 30; 26(3):301-16. PubMed ID: 9183819
    [Abstract] [Full Text] [Related]

  • 11. Role of glutamate receptors and nitric oxide on the effects of glufosinate ammonium, an organophosphate pesticide, on in vivo dopamine release in rat striatum.
    Faro LR, Ferreira Nunes BV, Alfonso M, Ferreira VM, Durán R.
    Toxicology; 2013 Sep 15; 311(3):154-61. PubMed ID: 23810826
    [Abstract] [Full Text] [Related]

  • 12. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.
    Gomes MZ, Raisman-Vozari R, Del Bel EA.
    Brain Res; 2008 Apr 08; 1203():160-9. PubMed ID: 18313645
    [Abstract] [Full Text] [Related]

  • 13. Role of nitric oxide in rotenone-induced nigro-striatal injury.
    He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, Appel SH, Le W.
    J Neurochem; 2003 Sep 08; 86(6):1338-45. PubMed ID: 12950443
    [Abstract] [Full Text] [Related]

  • 14. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
    Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):4565-71. PubMed ID: 8643444
    [Abstract] [Full Text] [Related]

  • 15. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism.
    Zeevalk GD, Manzino L, Hoppe J, Sonsalla P.
    Eur J Pharmacol; 1997 Feb 12; 320(2-3):111-9. PubMed ID: 9059843
    [Abstract] [Full Text] [Related]

  • 16. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
    Alfinito PD, Wang SP, Manzino L, Rijhsinghani S, Zeevalk GD, Sonsalla PK.
    J Neurosci; 2003 Nov 26; 23(34):10982-7. PubMed ID: 14645494
    [Abstract] [Full Text] [Related]

  • 17. Differential action of 7-nitro indazole on rat brain nitric oxide synthase.
    Kalisch BE, Connop BP, Jhamandas K, Beninger RJ, Boegman RJ.
    Neurosci Lett; 1996 Nov 22; 219(2):75-8. PubMed ID: 8971783
    [Abstract] [Full Text] [Related]

  • 18. Effects of nitric oxide synthase inhibitors on the discriminative stimulus effects of cocaine in rats.
    Collins SL, Edwards MA, Kantak KM.
    Psychopharmacology (Berl); 2001 Mar 22; 154(3):261-73. PubMed ID: 11351933
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide synthase inhibitors, 7-nitro indazole and nitroG-L-arginine methyl ester, dose dependently reduce the threshold for isoflurane anesthesia.
    Pajewski TN, DiFazio CA, Moscicki JC, Johns RA.
    Anesthesiology; 1996 Nov 22; 85(5):1111-9. PubMed ID: 8916829
    [Abstract] [Full Text] [Related]

  • 20. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
    Darvesh AS, Yamamoto BK, Gudelsky GA.
    J Pharmacol Exp Ther; 2005 Feb 22; 312(2):694-701. PubMed ID: 15456837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.